Cellular Biology |
From the Departments of Nephrology (R.K., C.D., M.K., J.H.), Clinical Pharmacology (M.P.), and Surgery (N.R.), Benjamin Franklin Medical Center, Freie Universität, Berlin, Germany.
| Abstract |
|---|
|
|
|---|
Key Words: single-cell RT-PCR endothelium Ca2+-activated K+ channels colonic cancer
| Introduction |
|---|
|
|
|---|
In vivo, the endothelium is a highly specialized cell monolayer at the interface between blood and tissue. The specialized functions of this endothelial cell (EC) layer could be considerably altered by cell isolation and culture. Thus, the function of ECs kept under artificial cell culture conditions does not necessarily reflect the functional state of the endothelium in highly differentiated blood vessels. Particularly, the function and molecular identity of KCa channels have not yet been elucidated in endothelium in situ despite their importance in the control of vascular function.
We therefore performed a study to identify and characterize KCa channel expression in endothelium of intact human mesenteric artery (MA) preparations. For this purpose, we adapted a single-cell reverse transcriptasepolymerase chain reaction (RT-PCR) approach in combination with the patch-clamp technique. This allows a simultaneous analysis of gene expression combined with the functional study of ion-channel function in small-vessel specimens in situ by avoiding alterations due to cell isolation and culture. In the present study we demonstrate expression of the human intermediate-conductance KCa (hIK1) and large-conductance KCa (hSlo) genes and its specific pattern within the ECs of intact MAs.
Endothelial function is disturbed in disease states such as hypertension, atherosclerosis, and angiogenesis.3 9 Regarding endothelial function during angiogenesis, there are indications for the involvement of endothelial ion-channel function and Ca2+ homeostasis in the initiation of angiogenesis in response to angiogenic factors.10 11 We tested whether expression and function of endothelial KCa channels of MAs are altered in patients with colonic adenocarcinoma (CA) compared with noncancer patients.
| Materials and Methods |
|---|
|
|
|---|
0.5 to 1 cm in length and 0.4 to 1.1
mm in outer diameter were excised out of the arterial
arcades from colon specimens of patients subjected to hemicolectomy.
Tissue collection was performed according to the guidelines of the
local ethics committee. Vessel slices of
2
mm2 were fixed on a glass capillary and placed in
the experimental chamber. For cell-harvesting procedures, vessel slices
were preincubated with 0.05% trypsin and 0.02% EDTA in PBS
without Ca2+/Mg2+
for up to 15 minutes. A 5-minute superfusion with PBS with
Ca2+/Mg2+ was performed to
stop the enzymatic reaction and wash out remaining trypsin and
contaminating cells. Under microscopic control, a slightly rounded EC
was then selectively fixed by aspiration at the tip of the patch
pipette and mechanically detached from the vessel wall.
Reverse Transcription
ECs and contents (
6 µL) of the pipette were expelled into a
tube containing 1 µL first-strand buffer (Life Technologies), 0.5
µL dNTPs (10 mmol/L each; Promega), 1 µL random-hexamer primer
(100 µmol/L; Boehringer Mannheim), 1 µL DTT (0.1
mol/L; Life Technologies), and 0.5 µL RNase inhibitor (40
U/µL; Promega). After 1 freeze-thaw cycle to induce breakdown of the
cell membrane, 0.5 µL SuperScript RT (200 U/µL; Life Technologies)
was added, and the final volume (
10 µL) was allowed to reverse
transcribe for 1 hour at 37°C. To exclude contamination by
nonendothelial mRNA, samples of bath solution were
aspirated next to the ECs.
Polymerase Chain Reaction
A modified single-cell RT-PCR was performed as described
previously.12 The most efficient PCR conditions, ie,
primer combination with maximal sensitivity,
MgCl2 concentration, number of cycles, and
annealing temperature, were determined by using a serial dilution of
human MA cDNA. First and nested primer pairs (TIB MOL BIOL) for
von Willebrand factor (vWF) and endothelial NO
synthase (eNOS) were selected to extend over intronic sequences. First
and nested primer pairs for hIK1 and hSlo were selected that yielded no
PCR product of expected size from genomic DNA of cell samples
processed without reverse transcription and from 50 ng/µL human DNA
after 2 PCR rounds. GenBank accession Nos. were the following: hIK1,
AF022797; hSlo, U13913; vWF, K03028; and eNOS, L26914.
In a single-cell sample, cDNA of hIK1 and hSlo were coamplified along
with the vWF cDNA as an EC marker and with myosin heavy chain (MyHC,
X69292) cDNA to exclude contamination with smooth muscle cell cDNA. A
first multiplex PCR was performed in a final volume of 50 µL
containing 5 µL PCR buffer (10x), 2 µL dNTPs (10 mmol/L
each), 3 µL MgCl2 (50 mmol/L), 1 µL of
each sense and antisense primer (10 pmol),
10 µL RT product,
and 0.5 µL Taq DNA polymerase (5 U/µL; all Life
Technologies) using a Biozym Maxicycler PTC 9600. Samples were
incubated for 5 minutes at 94°C, followed by 50 cycles of 30 seconds
at 94°C, 1 minute at 55°C, and 1 minute at 72°C and a final
elongation for 10 minutes at 72°C. In a second multiplex PCR round
with nested primers, 5 µL of the first PCR product was used for
reamplification (45 cycles with annealing temperature 60°C).
Amplified cDNAs were analyzed on a 2% agarose gel containing
ethidium bromide. A 50-bp DNA ladder (Life Technologies) was used for
molecular weight markers. Identities of the PCR products were
confirmed by restriction site analysis and by sequencing using
an ABI 377 automatic sequencer (ABI Prism). Primer pairs were as
follows: for hIK1, first, 5'-GAGAGGCAGGCTGTTAATGC-3' (positions
1075 to 1094) and 5'-TGAGACTCCTTCCTGCGGAGT-3' (positions 1400 to 1381),
and nested, 5'-CATCACATTCCTGACCATCG-3' (positions 1131 to 1150) and
5'-ACGTGCTTCTCTGCCTTGTT-3' (positions 1289 to 1270); for hSlo, first,
5'-GGACTTAGGGGATGGTGGTT-3' (positions 3237 to 3256) and
5'-GGGATGGAGTGAACAGAGGA-3' (positions 3533 to 3514), and nested,
5'-TTTACCGGCTG-AGAGATGCT-3' (positions 3314 to
3333) and 5'-GTGGGA-GGAATGGGACAG-3' (positions 3487 to
3469); for human vWF, first, 5'-GTTGTGGGAGATGTTTGCCT-3' (positions 61
to 80) and 5'-TGGAGTACATGGCTTTGCTG-3' (positions 426 to 407), and
nested, 5'-CACCATTCAGCTAAGAGGAGG-3' (positions 89 to 119) and
5'-GCCCTGGCAGTAGTGGATA-3' (positions 398 to 380); for eNOS, first,
5'-ATGTTTGTCTGCGGCGATGT-3' (positions 3382 to 3401) and
5'-AGGGGCTGTTGGTGTCTGAG-3' (positions 3661 to 3642), and nested,
5'-ATGGCAACCAACGTCCTG-3' (positions 3406 to 3423) and
5'-AAAAGCTCTGGGTGCGTATG-3' (positions 3586 to 3567); and for MyHC,
first, 5'-AAGTTCAAGTCCACCATCGC-3' (positions 2159 to 2178) and
5'-GAGTGTCCGTTTCCTCCTCA-3' (positions 2611 to 2590), and nested,
5'-GCCAAGATTGCACAGCTAGA-3' (positions 2189 to 2209)
and 5'-GCCTGAGCTTGCTCTTGAGT-3' (positions 2516 to 2497).
Patch-Clamp Experiments
Membrane currents were recorded with a nEPC-9 (HEKA)
patch-clamp amplifier and low-pass filtered (-3 dB, 1000 Hz) at a
sample time of 0.5 ms.13 The endothelial
membrane potential was recorded in the current-clamp mode. Patch
pipettes had a tip resistance of 2 to 4 MOhm in symmetrical KCl
solution. If not otherwise stated, the pipette solution contained
(in mmol/L) KCl 135, MgCl2 4, EGTA 1, and
HEPES 5 (pH 7.2). In some experiments the pipette solution additionally
contained 1 mmol/L CaCl2
([Ca2+]free=13
µmol/L). The NaCl bath solution contained (in mmol/L) NaCl 137,
Na2HPO4 4.5, KCl 3,
KH2PO4 1.5,
MgCl2 0.4, and CaCl2 0.7
(pH 7.4). The KCl bath solution contained (in mmol/L) KCl 140,
MgCl2 1, CaCl2 1, and HEPES
10 (pH 7.4). For excised inside-out patches, the cytosolic bath
solution contained (in mmol/L) KCl 140,
MgCl2 1, HEPES 10, and EGTA 10 (pH 7.2), with
CaCl2 added at concentrations yielding the
calculated [Ca2+]free
specified. All experiments were performed at 37°C. Data
analysis was performed as described previously.14
Leak currents were not subtracted before or during data acquisition.
All chemicals and toxins were obtained from Sigma.
Cancer and NonCancer Patients
For comparison of endothelial
KCa channel expression in disease states, MA
specimens of the arterial arcades were obtained from
patients undergoing colon resection for adenocarcinoma (n=8) and for
stenosis (n=7) due to noncancer reasons (diverticulitis or
nonspecific mucosal inflammation) as a control group. MAs from cancer
patients were prepared within an area 5 cm adjacent to the tumor. Colon
specimens from cancer and noncancer patients were
histologically analyzed by the local
pathologist. Colon specimens from 4 patients with diverticulitis and 1
patient with nonspecific mucosal inflammation showed no signs of
pericolonic inflammation at surgery. From 2 patients with
diverticulitis, which exhibited persisting signs of pericolonic
inflammation at surgery, MAs were prepared distantly from the affected
tissue. Characteristics of each patient from the respective groups are
summarized in the Table
.
|
Statistical Analysis
The Mann-Whitney U test was used to assess
differences between the 2 patient groups. Probability values of
P<0.05 were considered significant. If not otherwise
stated, data are given as mean±SE.
| Results and Discussion |
|---|
|
|
|---|
|
Because of its high sensitivity, the single-cell RT-PCR is
particularly vulnerable to giving false-positive RT-PCR signals by
minimal contamination from nonendothelial mRNA.
Therefore, every fifth sample was a medium sample (n=48) aspirated near
the endothelial surface. None of these medium samples
yielded a positive PCR signal. To rule out a harvest of vascular smooth
muscle cells or contamination by mRNA from leaking vascular smooth
muscle cells, we tested all samples for MyHC gene expression by the
multiplex RT-PCR technique. An RT-PCR signal for the MyHC cDNA was not
codetected in any of the cell samples (0 of 180). An eNOS-specific PCR
product was codetected in 62 of 77 (80%; in CA patients, 81%, and
in noncancer patients, 79%) vWF-positive cell samples (Figure 1B
). eNOS expression was never detected in vWF-negative samples.
The high rate of eNOS coexpression indicates the ability of NO
formation of these ECs and thus indicates preserved
endothelial function of these vessels.
KCa Channel Function and Expression in Single
ECs
Before single-cell RT-PCR analyses, we performed
single-channel and whole-cell patch-clamp experiments in electrically
uncoupled single ECs to verify channel function. For identification of
KCa currents, cells were dialyzed with a pipette
solution containing 13 µmol/L
[Ca2+]free. In a subset
of ECs, dialysis with Ca2+ induced a
hyperpolarizing outward current. The reversal potential
(Vrev) extrapolated from current-voltage
relations shifted by -39±5 mV (n=7) in noncancer patients and by
-49±2 mV (n=9, P=0.08) in CA patients toward the potassium
equilibrium potential, thus indicating K+ channel
activity (Figure 2A
). In a series
of experiments, in which Cl was substituted by
equal amounts of aspartate, membrane potential shifted to a similar
extent by 40±4 mV (n=6) in noncancer patients, thus indicating no
considerable contribution of
Ca2+-activated Cl-
channels to Ca2+-activated currents in
ECs from MA. The Ca2+-activated cell
current determined at a holding potential of 0 mV after subtraction of
leak currents measured at break-in and standardized to cell capacity
was 12±2 pA/pF in noncancer patients and 16±4 pA/pF in CA patients
(P=0.53) at 0 mV in 4.5 mmol/L K+
bath solution and 140 mmol/L K+ pipette
solution. Cell capacity was not different between CA patients (22±2
pF) and noncancer patients (20±4 pF). The
Ca2+-activated cell current was
K+ selective as reversal potential shifts
depended on the extracellular K+ concentration
(Figure 2B
). In symmetrical K+ solutions,
the K+ current exhibited slight inward
rectification in a membrane potential range of -100 to +100 mV. The
current was completely blocked by 100 nmol/L charybdotoxin (CTX;
n=6, Kd=6.0±0.2 nmol/L), a blocker of hIK1
and hSlo (Figure 2C
). Clotrimazole (CLT, 1
µmol/L, n=3, Figure 2D
), a more selective blocker of hIK1,
reduced the outward current by 90%;
Kd=148±22 nmol/L (Figure 2E
). In
contrast, apamin (100 nmol/L, n=3) had no effect on
K+ currents, thus indicating that
small-conductance KCa channels do not
considerably contribute to endothelial
KCa currents in endothelium of
MA.
|
The KCa current in ECs from MAs of both groups matched the properties of hIK1 and showed characteristics of inward rectification, CTX and CLT sensitivity, and Ca2+ dependence of channel activation comparable with those of human hIK1 cloned from human pancreas and T cells.15 16
Another type of K+ current fraction was detected
in a subset of ECs (n=4) from CA patients. Outward currents exhibited
voltage sensitivity with a characteristic current activation at
depolarizing membrane potentials in the range of +60 to +100 mV (Figure 2D
). Despite the small number of observations, these
K+ currents had hSlo characteristics and showed
similarities to whole-cell currents of human hSlo functionally
expressed in bovine pulmonary arterial
ECs.17
In inside-out single-channel recordings, we identified hIK1 in
both patient groups. In noncancer patients, hIK1 activity showed no
voltage sensitivity and exhibited inward rectification. Mean
single-channel conductance of hIK1 was 31±2 pS (n=5), with a
conductance of 42±2 pS at negative membrane potentials ranging from
-80 to -20 mV and 9±2 pS at positive membrane potentials ranging
from +20 to +100 mV (Figure 3A
).
In excised patches with a 140 mmol/L K+
pipette solution and a 4.5 mmol/L K+ bath
solution, hIK1 was selectively permeable for K+
(Figure 3B
). The extrapolated reversal potential was +42 mV,
corresponding to a K+:Na+
permeability ratio of 1:0.17, as calculated by the
Goldmann-Hodgkin-Katz equation.13 Single-channel activity
of hIK1 strongly depended on the Ca2+
concentration at the cytosolic face of the channel (Figure 3C
),
with half-maximal activation (EC50) at 352±61
nmol/L as determined at
[Ca2+]free ranging from
10 nmol/L to 20 µmol/L (Figure 3D
). In CA patients, the
hIK1 showed similar characteristics regarding
Ca2+ dependence (EC50
370±67 nmol/L) and mean conductance of 29±1 pS (n=8) and of 43±2 and
9±2 pS at negative and positive membrane potentials, respectively.
These single-channel properties of hIK1 in ECs from MAs of both groups
are comparable with those of human hIK1 cloned from human pancreas and
T cells.15 16
|
We estimated the hIK1 channel density per
hIK+ cell by assuming a single-channel amplitude
of
1 pA at 0 mV and an open probability
(Po) of
0.28 and by measuring peak
Ca2+-activated whole-cell currents at 0
mV to minimize contamination by nonselective and
Cl- currents. On the basis of these assumptions,
the estimated hIK1 density in ECs with a
hIK1+/hSlo- current
pattern was
740 channels per cell in noncancer patients and
930
channels per cell in CA patients.
Single-channel currents of hSlo were observed in ECs from CA patients.
hSlo (n=3) had a mean conductance of 208±16 pS (Figure 3E
),
exhibited no inward rectification, and showed voltage sensitivity with
increasing activity at depolarizing membrane potentials. In excised
patches with a 140 mmol/L K+ pipette
solution and a 4.5 mmol/L K+ bath solution,
hSlo was selectively permeable for K+ (Figure 3F
). The extrapolated reversal potential was +58 mV,
corresponding to a K+:Na+
permeability ratio of 1:0.08. hSlo activity was
Ca2+ dependent with an EC50
of
6 µmol/L cytosolic Ca2+ (n=1) at 0
mV (Figure 3G
).
We estimated hSlo density in a single EC with
hIK1+/hSlo+ current pattern
by assuming a single-channel amplitude of
25 pA and a
Po of
1 at +100 mV and by determining
the iberiotoxin (IbTX)sensitive peak
Ca2+-activated whole-cell current at +100
mV. On the basis of these assumptions, an estimated hSlo density in
hIK1+/hSlo+ cells of
35
channels per EC was calculated.
hSlo currents were not detected in 105 patches obtained from noncancer patients. This apparent lack of hSlo currents indicates that hSlo expression is very low or absent in ECs of noncancer patients.
Subsequent to patch-clamp measurements, single-cell RT-PCR
analysis revealed that all of the vWF+
cell samples (n=8) with an inwardly rectifying
KCa current fraction yielded a positive hIK1 PCR
signal (Figure 4
). In CA patients,
hSlo transcripts could be amplified from all ECs exhibiting
hSlo-related whole-cell currents (Figure 4
). The respective
KCa current fractions were sensitive to CLT and
to IbTX, a selective blocker of hSlo. hIK1 or hSlo transcripts could be
not amplified from any of the cell samples (n=14) with no
Ca2+-activated K+
current, although these samples were positive for vWF, indicating
successful EC harvesting. On the basis of this parallelism, single-cell
RT-PCR analysis apparently differentiates between
KCa channelexpressing and
KCa channellacking ECs. A
heterogeneity of channel expression within a population
of ECs of the monolayer and, moreover, a restriction of
Ca2+-activated K+
channel expression to a subset of ECs have not yet been described in
ECs. Regarding Ca2+ signaling, for example, the
generation of Ca2+ waves, a functional
heterogeneity within ECs, has thus far only been
described in lung capillary ECs, which indicated a pacemaker function
of some specialized ECs.18 It is tempting to speculate
that the subset of hIK1-expressing ECs might also represent a
specialized population of ECs for the control of membrane potential in
response to endothelial stimulation.
|
To characterize the functional role of KCa
channels in the control of membrane potential in both groups, we
performed current-clamp experiments in each vessel preparation and
determined resting potentials and agonist-induced
hyperpolarization in the electrically coupled ECs
of the intact monolayer. Application of bradykinin (100 nmol/L) induced
sustained hyperpolarization of the membrane
potential (Figure 5A
). In the presence of
100 nmol/L CTX (n=9), but not 100 nmol/L apamin, a blocker of
small-conductance KCa channels (n=5), membrane
potential shifts were completely reversed, thus confirming the activity
of CTX-sensitive KCa channels (Figure 5B
).
To discriminate the contribution of hIK1 and hSlo to bradykinin-induced
hyperpolarization of mesenteric
endothelium, we determined the blocking effects of CLT
(n=4) and IbTX (n=4). Application of CLT (1 µmol/L) shifted to
the same extent as CTX the membrane potential back to the resting
potential (Figure 5C
). In contrast, application of IbTX
(100 nmol/L, Figure 5D
) had no detectable effect on
bradykinin-induced hyperpolarization, although hSlo
expression was detected in the respective ECs from CA patients. This
indicated that activation of mainly hIK1 mediates
endothelial hyperpolarization in
response to bradykinin in both patient groups. Activation of hSlo seems
to play a minor role or no role in bradykinin-induced
hyperpolarization of mesenteric
endothelium from CA patients.
|
To relate electrophysiological and
RT-PCR data, we sought to determine whether the percentage of hIK1
expressing ECs per vessel correlates with the ability of the
endothelium to hyperpolarize in response to bradykinin.
The degree of bradykinin-induced hyperpolarization
correlated significantly with the percentage of hIK1-positive cells
collected from the respective vessel preparations (Figure 5E
).
This finding supports the idea of a predominant role of hIK1-expressing
ECs in the control of agonist-induced
hyperpolarization.
Comparison of Endothelial KCa Channel
Expression in MA From Cancer and NonCancer Patients
To demonstrate the usefulness of our technical approach, we tested
whether alterations of KCa channel expression and
function occur in disease states. Ca2+
homeostasis and K+ channel function in the
endothelium have been suggested to play a role in the
regulation of angiogenesis.10 11 We therefore compared
expression of hIK1 and hSlo in single ECs of MA specimens obtained from
CA patients (n=8) and from noncancer patients (n=7). To compare
KCa channel expression in
endothelium, 10 to 15 ECs were harvested from MA
preparations of each patient, and the percentage of
KCa-positive ECs was determined.
The percentage of hIK1-positive ECs per vessel was significantly
increased in MAs from CA patients compared with controls
(P<0.05; Figure 6A
). As
mentioned above, hSlo-positive ECs were exclusively detected in MAs
from CA patients (Figure 6B
). Interestingly, hSlo was
exclusively detected in hIK1-positive cell samples. This coexpression
might indicate that hSlo expression is coupled to hIK1 expression in
ECs from CA patients.
|
To determine whether increased percentage of
KCa channel-expressing ECs leads to an increased
ability of the endothelium of CA patients to
hyperpolarize in response to agonist-induced Ca2+
release from internal stores, we compared bradykinin-induced
hyperpolarization in endothelium of
MAs from each group. Resting potentials did not statistically differ
between CA patients (-32±5 mV) and controls (-28±5 mV, NS). The
degree of hyperpolarization in response to 100
nmol/L bradykinin was significantly increased in CA patients (shift of
membrane potential [
Vm], -22±4 mV)
compared with controls (
Vm, -8±3 mV,
P<0.05; Figure 6C
).
These data suggest that, compared with noncancer patients, increased expression of hIK1 in endothelium of MA from CA patients leads to considerably increased hyperpolarization in response to agonist stimulation. The physiological role of hSlo expression, which did not considerably contribute to endothelial hyperpolarization in CA patients, remains unclear.
Given that hIK1-mediated hyperpolarization increases the electrochemical driving force for Ca2+ influx, our findings may indicate an altered control of endothelial function and Ca2+ signaling in endothelium of MA from CA patients. hIK1 expression has been shown to regulate mitogenic cell growth and proliferation in other tissues, such as human fibroblasts,19 and in activated T lymphocytes.16 However, the question of whether the increased expression of hIK1 in endothelium of CA patients is indicative of mitogenic cell growth and angiogenesis requires further studies to resolve.
In conclusion, we newly established combined single-cell RT-PCR and patch-clamp analyses in human blood vessels. This allows functional and molecular biological characterization of single ECs in situ by avoiding alterations due to cell isolation and culture. We directly correlated expression and function of the KCa channels, hIK1 and hSlo, at the single-cell level. The heterogeneous expression patterns of hIK1 are indicative of a population of specialized ECs within the endothelium. A disease-related alteration in the expression pattern of KCa channels in cancer patients could be involved in endothelial function during angiogenesis.
| Acknowledgments |
|---|
| Footnotes |
|---|
Received April 4, 2000; revision received July 19, 2000; accepted July 20, 2000.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
S. Pokojski, C. Busch, I. Grgic, M. Kacik, W. Salman, R. Preisig-Muller, W.-T. Heyken, J. Daut, J. Hoyer, and R. Kohler TWIK-related two-pore domain potassium channel TREK-1 in carotid endothelium of normotensive and hypertensive mice Cardiovasc Res, April 3, 2008; (2008) cvn069v2. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-Z. Sheng and A. P. Braun Small- and intermediate-conductance Ca2+-activated K+ channels directly control agonist-evoked nitric oxide synthesis in human vascular endothelial cells Am J Physiol Cell Physiol, July 1, 2007; 293(1): C458 - C467. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. P. Marrelli, R. G. O'Neil, R. C. Brown, and R. M. Bryan Jr. PLA2 and TRPV4 channels regulate endothelial calcium in cerebral arteries Am J Physiol Heart Circ Physiol, March 1, 2007; 292(3): H1390 - H1397. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Si, W.-T. Heyken, S. E. Wolfle, M. Tysiac, R. Schubert, I. Grgic, L. Vilianovich, G. Giebing, T. Maier, V. Gross, et al. Impaired Endothelium-Derived Hyperpolarizing Factor-Mediated Dilations and Increased Blood Pressure in Mice Deficient of the Intermediate-Conductance Ca2+-Activated K+ Channel Circ. Res., September 1, 2006; 99(5): 537 - 544. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Bryan Jr., J. You, S. C. Phillips, J. J. Andresen, E. E. Lloyd, P. A. Rogers, S. E. Dryer, and S. P. Marrelli Evidence for two-pore domain potassium channels in rat cerebral arteries Am J Physiol Heart Circ Physiol, August 1, 2006; 291(2): H770 - H780. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Feletou and P. M. Vanhoutte Endothelium-Derived Hyperpolarizing Factor: Where Are We Now? Arterioscler. Thromb. Vasc. Biol., June 1, 2006; 26(6): 1215 - 1225. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. M. Jones, K. L. Hamilton, and D. C. Devor Role of an S4-S5 Linker Lysine in the Trafficking of the Ca2+-activated K+ Channels IK1 and SK3 J. Biol. Chem., November 4, 2005; 280(44): 37257 - 37265. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Grgic, I. Eichler, P. Heinau, H. Si, S. Brakemeier, J. Hoyer, and R. Kohler Selective Blockade of the Intermediate-Conductance Ca2+-Activated K+ Channel Suppresses Proliferation of Microvascular and Macrovascular Endothelial Cells and Angiogenesis In Vivo Arterioscler. Thromb. Vasc. Biol., April 1, 2005; 25(4): 704 - 709. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. D. Gutterman, H. Miura, and Y. Liu Redox Modulation of Vascular Tone: Focus of Potassium Channel Mechanisms of Dilation Arterioscler. Thromb. Vasc. Biol., April 1, 2005; 25(4): 671 - 678. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Visan, Z. Fajloun, J.-M. Sabatier, and S. Grissmer Mapping of Maurotoxin Binding Sites on hKv1.2, hKv1.3, and hIKCa1 Channels Mol. Pharmacol., November 1, 2004; 66(5): 1103 - 1112. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Ouadid-Ahidouch, M. Roudbaraki, P. Delcourt, A. Ahidouch, N. Joury, and N. Prevarskaya Functional and molecular identification of intermediate-conductance Ca2+-activated K+ channels in breast cancer cells: association with cell cycle progression Am J Physiol Cell Physiol, July 1, 2004; 287(1): C125 - C134. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. M. Jones, K. L. Hamilton, G. D. Papworth, C. A. Syme, S. C. Watkins, N. A. Bradbury, and D. C. Devor Role of the NH2 Terminus in the Assembly and Trafficking of the Intermediate Conductance Ca2+-activated K+ Channel hIK1 J. Biol. Chem., April 9, 2004; 279(15): 15531 - 15540. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Brakemeier, A. Kersten, I. Eichler, I. Grgic, A. Zakrzewicz, H. Hopp, R. Kohler, and J. Hoyer Shear stress-induced up-regulation of the intermediate-conductance Ca2+-activated K+ channel in human endothelium Cardiovasc Res, December 1, 2003; 60(3): 488 - 496. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Begg, F.-M. Mo, L. Offertaler, S. Batkai, P. Pacher, R. K. Razdan, D. M. Lovinger, and G. Kunos G Protein-coupled Endothelial Receptor for Atypical Cannabinoid Ligands Modulates a Ca2+-dependent K+ Current J. Biol. Chem., November 14, 2003; 278(46): 46188 - 46194. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Kohler, H. Wulff, I. Eichler, M. Kneifel, D. Neumann, A. Knorr, I. Grgic, D. Kampfe, H. Si, J. Wibawa, et al. Blockade of the Intermediate-Conductance Calcium-Activated Potassium Channel as a New Therapeutic Strategy for Restenosis Circulation, September 2, 2003; 108(9): 1119 - 1125. [Abstract] [Full Text] [PDF] |
||||
![]() |
K A Bowley, M J Morton, M Hunter, and G I Sandle Non-genomic regulation of intermediate conductance potassium channels by aldosterone in human colonic crypt cells Gut, June 1, 2003; 52(6): 854 - 860. [Abstract] [Full Text] |
||||
![]() |
C. A. Syme, K. L. Hamilton, H. M. Jones, A. C. Gerlach, L. Giltinan, G. D. Papworth, S. C. Watkins, N. A. Bradbury, and D. C. Devor Trafficking of the Ca2+-activated K+ Channel, hIK1, Is Dependent upon a C-terminal Leucine Zipper J. Biol. Chem., February 28, 2003; 278(10): 8476 - 8486. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Szado, M. McLarnon, X. Wang, and C. van Breemen Role of sarcoplasmic reticulum in regulation of tonic contraction of rabbit basilar artery Am J Physiol Heart Circ Physiol, October 1, 2001; 281(4): H1481 - H1489. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Kohler, S. Brakemeier, M. Kuhn, C. Degenhardt, H. Buhr, A. Pries, and J. Hoyer Expression of ryanodine receptor type 3 and TRP channels in endothelial cells: comparison of in situ and cultured human endothelial cells Cardiovasc Res, July 1, 2001; 51(1): 160 - 168. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. A. Coleman, M. Tare, and H. C. Parkington EDHF is not K+ but may be due to spread of current from the endothelium in guinea pig arterioles Am J Physiol Heart Circ Physiol, June 1, 2001; 280(6): H2478 - H2483. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Kohler, S. Brakemeier, M. Kuhn, C. Behrens, R. Real, C. Degenhardt, H.-D. Orzechowski, A. R. Pries, M. Paul, and J. Hoyer Impaired Hyperpolarization in Regenerated Endothelium After Balloon Catheter Injury Circ. Res., July 20, 2001; 89(2): 174 - 179. [Abstract] [Full Text] [PDF] |
||||
| ||||||||